GRAFT POLYMER UK LS -001
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre-cl… Read more
Market Cap & Net Worth: GRAFT POLYMER UK LS -001 (J4I)
GRAFT POLYMER UK LS -001 (F:J4I) has a market capitalization of $17.47 Million (€17.02 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #28520 globally and #3127 in its home market, demonstrating a 25.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GRAFT POLYMER UK LS -001's stock price €0.00 by its total outstanding shares 6806403493 (6.81 Billion).
GRAFT POLYMER UK LS -001 Market Cap History: 2022 to 2026
GRAFT POLYMER UK LS -001's market capitalization history from 2022 to 2026. Data shows change from $985.11 Million to $17.47 Million (-67.00% CAGR).
GRAFT POLYMER UK LS -001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GRAFT POLYMER UK LS -001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of J4I by Market Capitalization
Companies near GRAFT POLYMER UK LS -001 in the global market cap rankings as of March 18, 2026.
Key companies related to GRAFT POLYMER UK LS -001 by market ranking:
- GE Vernova LLC (NYSE:GEV): Ranked #66 globally with a market cap of $227.10 Billion USD.
- Siemens Aktiengesellschaft (XETRA:SIE): Ranked #93 globally with a market cap of $175.49 Billion USD ( €170.96 Billion EUR).
- Siemens AG Class N (PINK:SMAWF): Ranked #113 globally with a market cap of $155.24 Billion USD.
- Eaton Corporation PLC (NYSE:ETN): Ranked #140 globally with a market cap of $133.05 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #66 | GE Vernova LLC | NYSE:GEV | $227.10 Billion | $844.05 |
| #93 | Siemens Aktiengesellschaft | XETRA:SIE | $175.49 Billion | €219.15 |
| #113 | Siemens AG Class N | PINK:SMAWF | $155.24 Billion | $199.00 |
| #140 | Eaton Corporation PLC | NYSE:ETN | $133.05 Billion | $363.95 |
GRAFT POLYMER UK LS -001 Historical Marketcap From 2022 to 2026
Between 2022 and today, GRAFT POLYMER UK LS -001's market cap moved from $985.11 Million to $ 17.47 Million, with a yearly change of -67.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €17.47 Million | +150.00% |
| 2025 | €6.99 Million | +100.00% |
| 2024 | €3.49 Million | 0.00% |
| 2023 | €3.49 Million | -99.65% |
| 2022 | €985.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GRAFT POLYMER UK LS -001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.47 Million USD |
| MoneyControl | $17.47 Million USD |
| MarketWatch | $17.47 Million USD |
| marketcap.company | $17.47 Million USD |
| Reuters | $17.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.